Arginine vasopressin increases nitric oxide synthesis in cytokine- stimulated rat cardiac myocytes

Hypertension

Volumn 30, Issue 5, 1997, Pages 1112-1120

  Yamamoto, Keiji ^a   Ikeda, Uichi ^a   Okada, Koji ^a   Saito, Toshikazu ^a   Kawahara, Yasuhiro ^b   Okuda, Masanori ^b   Yokoyama, Mitsuhiro ^b   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcium; Endothelium derived factors; Interleukins

Indexed keywords

ARGIPRESSIN; CALPHOSTIN; CYTOKINE; NITRIC OXIDE; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL TONE; CELL STIMULATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INDUCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SECOND MESSENGER; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE;

EID: 0030680263     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.5.1112     Document Type: Article

References (55)

1. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 1992;256:225-228.
2. Cho HJ, Xie QW, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Nathan C. Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp. Med. 1992;176:599-604.
3. Yui Y, Hattori R, Kosuga K, Eizawa H, Hiki K, Kawai C. Purification of nitric oxide synthase from rat macrophages. J Biol Chem. 1991;266:12544-12547.
4. Hevel JM, White KA, Marletta MA. Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein. J Biol Chem. 1991;266:22789-22791.
5. Lyons CR, Orloff GJ, Cunningham JM. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem. 1992;267:6370-6374.
6. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci U S A. 1992;89:6711-6715.
7. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43: 109-140.
8. Hosenpud JD, Campbell SM, Mendelson DJ. Interleukin-1-induced myocardial depression in an isolated beating heart preparation. J Heart Transplant. 1989;8:460-464.
9. Roberts AB, Roche NS, Winokur TS, Burmester JK, Sporn MB. Role of transforming growth factor-β in maintenance of function of cultured neonatal cardiac myocytes. J Clin Invest. 1992;90: 2056-2062.
10. Finkel MS, Odis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-389.
11. Balligand JL, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Michel T, Smith TW. Abnormal contractile function due to induction of nitric oxide synthase in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 1993;91:2314-2319.
12. Ungureanu-Longrois D, Balligand JL, Simmons WW, Okada I. Kobzik L. Lowenstein CJ, Kunkel S, Michel T, Kelly RA, Smith TW. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to β-adrenergic agonists. Circ Res. 1995; 77:494-502.
13. Shindo T, Ikeda U, Ohkawa F, Kawahara Y, Yokoyama M, Shimada K. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc Res. 1995;29:813-819.
14. Suffredini AF, Fromm RF, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989; 321:280-287.
15. Nora R, Abrams JS, Tait NS, Hiponia DJ, Silverman HJ. Myocardial toxic effects during recombinant interleukin-2 therapy. J Natl Cancer Inst. 1989;81:59-63.
16. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH. Cooke JP, McKenna WJ, Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 1996;93: 1087-1094.
17. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumor necrosis factor and inducible nitric oxide synthesis in dilated cardiomyopathy. Lancet. 1996;347:1151-1155.
18. Laszlo FA, Laszlo F Jr, Wide DD. Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacol Rev. 1991;43: 73-108.
19. 1a type. Am J Physiol. 1987;253:F41-F49.
20. Jard S, Barberis C, Audigier S, Tribollet E. Neurohypophyseal hormone receptor systems in brain and periphery. Prog Brain Res. 1987;72:173-187.
21. 1a arginine vasopressin receptor. Nature. 1992;356:523-526.
22. 1a vasopressin receptor. J Biol Chem. 1994;269:3304-3310.
23. Buckingham JC. Vasopressin receptors influencing the secretion of ACTH by the rat adenohypophysis. J Endocrinol. 1987;113:389-396.
24. 1b vasopressin receptor: evidence for its expression in extra-pituitary tissues. Biochem Biophys Res Commun. 1995;212:751-757.
25. 1b vasopressin receptor. J Biol Chem. 1994;269:27088-27092.
26. Raymond V, Leung PCK, Veilleux R, Labrie F. Vasopression rapidly stimulates phosphatidic acid-phosphatidylinositol turnover in rat anterior pituitary cells. FEBS Lett. 1985;182:196-200.
27. Jard S, Mechanisms of action of vasopressin and vasopressin antagonists. Kidney Int. 1988;26(suppl):S38-S42.
28. 2 receptor and possible link to nephrogenic diabetes insipidus. Nature. 1992;357:336-339.
29. Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis C, Antaramian A, Barbet P, Rosenthal W. Molecular cloning of the receptor for human antidiuretic hormone. Nature. 1992;357: 333-335.
30. Scott-Burden T, Elizondo E, Ge T, Boulanger CM, Vanhoutte PM. Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells. Mol Pharmacol 1994;46:274-282.
31. Kadowaki K, Kishimoto J, Leng G, Emson PC. Up-regulation of nitric oxide synthase (NOS) gene expression together with NOS activity in the rat hypothalamo-hypophysial system after chronic salt loading: evidence of a neuromodulatory role of nitric oxide in arginine vasopressin and oxytocin secretion. Endocrinology. 1994; 134:1011-1017.
32. Laszlo F, Whittle BJR. Constitutive nitric oxide modulates the injurious actions of vasopressin on rat intestinal microcirculation in acute endotoxaemia. Eur J Phannacol. 1994;260:265-268.
33. Yamane Y. Plasma ADH levels in patients with chronic congestive heart failure. Jpn Circ J. 1968;32:763-770.
34. Goldsmith SR, Francis GS, Cowley AW, Levine TB, Cohn JN. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol. 1983;1:1385-1390.
35. Benedict CR, Johnstone DE, Weiner DH, Bourassa MG, Bittner V. Kay R, Kirlin P, Greenberg B, Kohn RM, Nicklas JM, McIntyre K, Quinones MA, Yusuf S, for the SOLVD investigators. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the registry of studies of left ventricular dysfunction. J Am Coll Cardiol. 1994;23:1410-1420.
36. Ohshima H, Brouet IM, Bandaletova T, Adachi H, Oguchi S, Iida S, Kurashima Y, Morishita Y, Sugimura T, Esumi H. Polyclonal antibody against an inducible form of nitric oxide synthase purified from the liver of rats treated with Propionihaeterium acnes and lipopolysaccharide. Biochem Biophys Res Commun. 1992;187: 1291-1297.
37. Yamamoto K, Ikeda U, Seino Y, Tsuruya Y, Oguchi A, Okada K, Ishikawa S, Sako T, Kawakami K, Hara Y, Shimada K. Regulation of Na,K-ATPase gene expression by sodium ions in cultured neonatal rat cardiocytes. J Gin Invest. 1993;92:1889-1895.
38. Kamitani T, Ikeda U, Muto S, Kawakami K, Nagano K, Tsuruya Y, Oguchi A, Yamamoto K, Hara Y, Kojima T, Medford RM, Shimada K. Regulation of Na,K-ATPase gene expression by thyroid hormone in rat cardiocytes. Circ Res. 1992;71:1457-1464.
39. Hattori Y, Nakanishi, N. Effects of cyclosporine A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages. Cell Immunol. 1995; 165:7-11.
40. Green LC, Wagner DA, Analysis of nitrate, nitrite, and (15N) nitrate in biological fluids. Anal Biochem. 1982;126:131-138.
41. Koide M, Kawahara Y, Tsuda T, Yokoyama M. Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett. 1943;318: 213-217.
42. Koide M, Kawahara Y, Nakayama I, Tsuda T, Yokovama M. Cyclic AMP-elevating agents induce an inducible-type of nitric oxide synthase in cultured vascular smooth muscle cells. J Biol Chem. 1993;268:24959-24966.
43. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
44. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
45. Yasuda I, Kishimoto A, Tanaka S, Tominaga M, Sukurai A, Nishizuka Y. A synthetic peptide substrate for selective assay of protein kinase C. Biochem Biophys Res Commun. 1990;166: 1220-1227.
46. Ikeda U, Maeda Y, Kawahara Y, Yokoyama M, Shimada K. Angiotensin II augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. Circulation. 1995;92:2683-2689.
47. Mckenna TM, Li S, Tao S. PKC mediates LPS- and phorbol-induced cardiac cell nitric oxide synthase activity and hypocontractility. Am J Physiol. 1995;269:H1891-H1898.
48. Clerk A, Bogoyevich MA, Fuller SJ, Lazou A, Parker PJ, Sugden PH. Expression of protein kinase C isoforms during cardiac ventricular development. Am J Physiol. 1995;269:H1087-H1097.
49. Suzuki S, Takeshita A, Imaizumi Y, Hirooka Y, Yoshida M, Ando S, Nakamura M. Biphasic forearm vascular response to intraarterial vasopressin. J Clin Invest. 1989;84:427-434.
50. Hirsch A, Dzau V, Majzoub J, Creager M. Vasopressin-mediated forearm vasodilation in normal humans. J Clin Invest. 1989;84: 418-426.
51. 2 receptor mRNA in rats. Eur J Pharmacol. 1994;267:71-75.
52. 1a vasopressin receptor gene. Genomics. 1996;31:327-334.
53. Balligand J-L, Kohzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW, Michel T. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem. 1995;270:14582-14586.
54. Simon J, Kasson BG. Identification of vasopressin mRNA in rat aorta. Hypertension. 1995;25:1030-1033.
55. Lim ATW, Lolait SJ, Barlow JW, Autelitano DJ, Toh BH, Boublik J, Abraham J, Johnson CI, Funder JW. Immunoreactive arginine-vasopressin in Brattlehoro rat ovary. Nature. 1984;310:61-64.